Targeted Gynecologic Expansion Histologics is actively expanding use of Kylon devices in gynecologic procedures such as epithelial curettage and colposcopy, presenting a sales opportunity to gynecology clinics, CIS, and women's health networks seeking less invasive biopsy solutions.

Wound Care Positioning Kylon devices offer controlled debridement with reduced trauma and potential faster healing, creating a value proposition for wound care centers and chronic wound programs looking to improve patient outcomes and differentiate their service offerings.

Global Market Growth Recent press highlights global expansion of Kylon biopsy devices, suggesting opportunity with international distributors, hospital networks, and regional healthcare systems seeking innovative sampling and diagnostic tools.

Key Thought Leadership Dr. Neal Lonky’s prominence in female health and early cancer detection can be leveraged for credibility-led outreach, co-marketing, and speaker engagements to accelerate adoption among leading clinics and academic centers.

Strategic Partnerships The company’s small to mid-market size and specialized tissue-based technology indicate a strong fit for partnerships with diagnostic labs, pathology groups, and surgical device distributors aiming to expand portfolio with minimally invasive biopsy devices.